UVA findings holds promise for developing targeted treatments for Long COVID lung complications
4 Articles
4 Articles
The Fight to Be Believed: Long COVID’s Toll on Black Americans
This article is part of a collaboration with the Associated Press, Capital B, and Flint Beat. The work is part of the AP Inclusive Journalism Initiative supported by the Sony Foundation. Chimére L. Sweeney, a Maryland middle school teacher, was preparing to lead one of her first online classes after the pandemic shutdowns in March 2020 when she said she suddenly felt like someone placed a lit match on her spine. Over the next several weeks, Swee…
UVA findings holds promise for developing targeted treatments for Long COVID lung complications
Groundbreaking research from the University of Virginia School of Medicine has revealed crucial new insights into the immune systems of COVID-19 survivors, particularly those struggling with persistent breathing issues.
Immune system shifts may explain why some long COVID patients struggle to breathe
Research from the University of Virginia School of Medicine has revealed crucial new insights into the immune systems of COVID-19 survivors, particularly those struggling with persistent breathing issues. The study shows that these patients have distinct changes in their immune system that link to the severity of their lung damage. This discovery holds promise for developing targeted treatments for the lung complications of long COVID.
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage